Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1979-04-05
1980-08-12
Sutto, Anton H.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
260403, 260946, A61K 3166, C07F 940
Patent
active
042173469
ABSTRACT:
Arylalkyl and aryloxyalkylphosphonates, useful as antiviral agents, are prepared by reacting an arylalkyl or aryloxyalkyl halide with a trialkyl phosphite, or with an alkali metal salt of a dialkyl phosphonate, trialkyl phosphonoalkanoate or dialkyl phosphonoalkanone.
REFERENCES:
patent: 3917718 (1975-11-01), Collins
patent: 4031246 (1977-06-01), Collins et al.
patent: 4045468 (1977-08-01), Kurono et al.
Baron et al., "Annual Reports in Medicinal Chemistry", vol. 10 (1975), Chapter on Antiviral Agents, p. 166.
Linn et al., "J. Am. Chem. Soc.", vol. 87, (1965), pp. 3657-3672.
Johnson Thomas L.
Sterling Drug Inc.
Sutto Anton H.
Wyatt B. Woodrow
LandOfFree
Arylalkyl and aryloxyalkyl phosphonates as antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylalkyl and aryloxyalkyl phosphonates as antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylalkyl and aryloxyalkyl phosphonates as antiviral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2182503